These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7104162)

  • 41. [Comparative studies on the bioavailability of paracetamol from suppositories].
    Müller BW; Franzky HJ; Kölln CJ; Mengel W
    Arzneimittelforschung; 1984; 34(10):1319-22. PubMed ID: 6549135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation of paired plasma and saliva paracetamol levels following deliberate self-poisoning with paracetamol (the Salivary Paracetamol In Toxicology [SPIT] study).
    Wade H; McCoubrie DL; Fatovich DM; Ryan J; Vasikaran S; Daly FF
    Clin Toxicol (Phila); 2008 Jul; 46(6):534-8. PubMed ID: 18584366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative pharmacokinetics of paracetamol in men and women considering follicular and luteal phases.
    Wójcicki J; Gawrońska-Szklarz B; Kazimierczyk J; Baskiewicz Z; Raczyński A
    Arzneimittelforschung; 1979; 29(2):350-2. PubMed ID: 582149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Paracetamol estimation: comparison of a quick colorimetric method with a standard spectrophotometric method.
    Wiener K
    Ann Clin Biochem; 1977 Jan; 14(1):55-8. PubMed ID: 843062
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparative pharmacokinetics and biologic availability of paracetamol as suppositories].
    Degen J; Maier-Lenz H
    Arzneimittelforschung; 1984; 34(8):900-2. PubMed ID: 6541925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of microsomal enzyme induction on paracetamol metabolism in man.
    Prescott LF; Critchley JA; Balali-Mood M; Pentland B
    Br J Clin Pharmacol; 1981 Aug; 12(2):149-53. PubMed ID: 7306429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Absolute bioavailability of paracetamol after oral or rectal administration in healthy volunteers.
    Eandi M; Viano I; Ricci Gamalero S
    Arzneimittelforschung; 1984; 34(8):903-7. PubMed ID: 6548636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of intravenous atropine on gastric emptying, paracetamol absorption, salivary flow and heart rate in young and fit elderly volunteers.
    Rashid MU; Bateman DN
    Br J Clin Pharmacol; 1990 Jul; 30(1):25-34. PubMed ID: 2390429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitamin C, omega-3 and paracetamol pharmacokinetic interactions using saliva specimens as determiners.
    Jaccob AA; Ahmed ZH; Aljasani BM
    J Basic Clin Physiol Pharmacol; 2019 Aug; 30(5):. PubMed ID: 31393833
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Data point weighting in pharmacokinetic analysis: intravenous paracetamol in man.
    Clements JA; Prescott LF
    J Pharm Pharmacol; 1976 Sep; 28(9):707-9. PubMed ID: 10395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monitoring prednisolone and prednisone in saliva: a population pharmacokinetic approach in healthy volunteers.
    Teeninga N; Guan Z; Freijer J; Ruiter AF; Ackermans MT; Kist-van Holthe JE; van Gelder T; Nauta J
    Ther Drug Monit; 2013 Aug; 35(4):485-92. PubMed ID: 23783167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lincomycin serum and saliva concentrations after intramuscular injection of high doses.
    Smith RB; Lummis WL; Monovich RE; DeSante KA
    J Clin Pharmacol; 1981 Oct; 21(10):411-7. PubMed ID: 7309904
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of study protocol on the interactions between cimetidine and paracetamol in man.
    Garba M; Odunola MT; Ahmed BH
    Eur J Drug Metab Pharmacokinet; 1999; 24(2):159-62. PubMed ID: 10510744
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of chrysin on the formation of N-acetyl-p-benzoquinoneimine, a toxic metabolite of paracetamol in rats and isolated rat hepatocytes.
    Pingili RB; Pawar AK; Challa SR
    Chem Biol Interact; 2019 Apr; 302():123-134. PubMed ID: 30794797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of the metabolism of paracetamol by isoniazid.
    Epstein MM; Nelson SD; Slattery JT; Kalhorn TF; Wall RA; Wright JM
    Br J Clin Pharmacol; 1991 Feb; 31(2):139-42. PubMed ID: 2049229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pharmacokinetics of two erythromycin esters in plasma and in saliva following oral administration in humans.
    Ducci M; Scalori V; del Tacca M; Soldani G; Bernardini C; Grothe E; Bertelli A
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):494-7. PubMed ID: 7298242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of metronidazole in saliva.
    Mustofa ; Suryawati S; Santoso B
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):474-8. PubMed ID: 1813432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of migraine attacks on paracetamol absorption.
    Tokola RA; Neuvonen PJ
    Br J Clin Pharmacol; 1984 Dec; 18(6):867-71. PubMed ID: 6529526
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Assessment of Liver Reserve Function by Spectrophotometry based on Determination of Phenacetin and Paracetamol.
    Ren R; Ma Y; Ma W; Lu S
    Clin Lab; 2015; 61(12):1927-34. PubMed ID: 26882817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The relative bioavailability of paracetamol in suppositories in comparison to tablets].
    Blume H; Ali SL; Elze M; Krämer J; Scholz ME
    Arzneimittelforschung; 1996 Oct; 46(10):975-80. PubMed ID: 8992964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.